Neuroinmunología
- Número de publicaciones
- 112
Publicaciones
-
Ramo-Tello C; Blanco Y; Brieva L; Casanova B; Martínez-Cáceres E; Ontaneda D; Ramió-Torrentá L; Rovira À
Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.
Journal of Personalized Medicine 12 -. .
-
Munoz-Lopetegi, A; Pujol, M; Gimenez, M; Gaig, C; Brieva, L; Santamaria, J
Abnormal sleep behavior caused by hypoglycemia
SLEEP MEDICINE 85 268-270. .
-
Jorge C; Cetó M; Arias A; Blasco E; Gil MP; López R; Dakterzada F; Purroy F; Piñol-Ripoll G
Level of understanding of Alzheimer disease among caregivers and the general population.
Neurologia (barcelona, Spain) 36 426-432. .
-
Meca-Lallana, J; Garcia-Merino, JA; Martinez-Yelamos, S; Vidal-Jordana, A; Costa, L; Eichau, S; Rovira À; Brieva, L; Aguera, E; Zarranz, ARA
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.
Neurodegenerative Disease Management 11 251-261. .
-
Sanchez-Cazalilla, Marta; Gonzalez-Mingot, Cristina; Torterolo, Giovanni; Torrent, Aurora; Batalla, Iolanda
Episodic Ataxia Misdiagnosed as Anxiety Disorder.
The Primary Care Companion For Cns Disorders 23 -. .
-
Fernandez-Velasco, JI; Kuhle, J; Monreal, E; Meca-Lallana, V; Meca-Lallana, J; Izquierdo, G; Gascon-Gimenez, F; de la Maza, SS; Walo-Delgado, PE; Maceski, A; Rodriguez-Martin, E; Roldan, E; Villarrubia, N; Saiz, A; Blanco, Y; Sanchez, P; Carreon-Guarnizo, E; Aladro, Y; Brieva, L; Iniguez, C; Gonzalez-Suarez, I; de Antonio, LAR; Masjuan, J; Costa-Frossard, L; Villar, LM
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
Neurology-Neuroimmunology & Neuroinflammation 8 -. .
-
Maurino J; Sotoca J; Sempere ÁP; Brieva L; López de Silanes C; Caminero AB; Terzaghi M; Gracia-Gil J; Saposnik G
High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.
Patient-Patient Centered Outcomes Research 14 241-248. .
-
Purroy F; Vicente-Pascual M; Arque G; Baraldes-Rovira M; Begue R; Gallego Y; Gil MI; Gil-Villar MP; Mauri G; Quilez A; Sanahuja J; Vazquez-Justes D
Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.
STROKE 52 424-433. .
-
Avila, A; Pastor, P; Planellas, L; Gil-Villar, MP; Hernandez-Vara, J; Fernandez-Dorado, A
DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia
REVISTA DE NEUROLOGIA 72 1-8. .
-
Otero-Romero S; Rodríguez-García J; Vilella A; Ara JR; Brieva L; Calles C; Carmona O; Casanova V; Costa-Frossard L; Eichau S; García-Merino JA; Garcia-Vidal C; González-Platas M; Llaneza M; Martínez-Ginés M; Meca-Lallana JE; Prieto JM; Rodríguez-Antigüedad A; Tintoré M; Blanco Y; Moral E
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.
Neurologia (barcelona, Spain) 36 50-60. .
-
Meca-Lallana, J. E.; Fernandez-Prada, M.; Garcia Vazquez, E.; Moreno Guillen, S.; Otero Romero, S.; Rus Hidalgo, M.; Villar Guimerans, L. M.; Eichau Madueño S; Fernandez Fernandez, O.; Izquierdo Ayuso, G.; Álvarez Cermeño JC; Arnal Garcia, C.; Arroyo Gonzalez, R.; Brieva Ruiz, L.; Calles Hernandez, C.; Garcia Merino, A.; Gonzalez Platas, M.; Hernandez Perez, M. A.; Moral Torres, E.; Olascoaga Urtaza, J.; Oliva-Nacarino, P.; Oreja-Guevara, C.; Ortiz Castillo, R.; Oterino, A.; Prieto Gonzalez, J. M.; Ramio-Torrenta, L.; Rodriguez-Antiguedad, A.; Saiz, A.; Tintore, M.; Montalban Gairin, X.
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
NEUROLOGIA 37 615-630. .
-
Meca-Lallana, J; Maurino, J; Hernández-Pérez MÁ; Sempere, AP; Brieva, L; García-Arcelay E; Terzaghi, M; Saposnik, G; Ballesteros, J
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.
Neurology and Therapy 9 173-179. .
